Mark Sabag sold $6.1M of Teva Pharmaceutical Industries Limited (TEVA)

Executed May 8 2025, disclosed May 12 2025, 4 days later.

Value, as filed

$6.1M

337,915 sh × $18.04

Executed

May 8 2025

the trade date, as filed

Disclosed

May 12 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Mark Sabag See "Remarks" profile →

Mark Sabag (See "Remarks") filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $6.2M of TEVA (216,892 sh across 2 lots, as filed), executed Dec 9 2025.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 60 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mark Sabag in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $1.9M
46,000 sh × $41.93
Exec Nov 5
Filed Nov 6 · 4:03 PM ET TEVASALE Teva Pharmaceutical Industries Limited $5.0M
144,180 sh × $34.99
Exec May 1
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.9M
62,102 sh × $30.14
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $6.2M
216,892 sh across 2 lots
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $2.9M
177,626 sh × $16.25
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET